(株)リボミックの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4591/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/04/06 | 日証協 | 269,400株 | -7.74% | 34,100株 | +135.17% | 352,136株 | +10.63% | 19,205株 | -40.91% |
2018/03/30 | 日証協 | 292,000株 | -6.65% | 14,500株 | -82.14% | 318,301株 | -16.49% | 32,500株 | +1254.17% |
2018/03/23 | 日証協 | 312,800株 | +6.94% | 81,200株 | -26.05% | 381,136株 | +1.92% | 2,400株 | -97.13% |
2018/03/16 | 日証協 | 292,500株 | -1.85% | 109,803株 | +173.12% | 373,943株 | -1.19% | 83,500株 | +838.2% |
2018/03/09 | 日証協 | 298,000株 | +5.67% | 40,203株 | -31.28% | 378,459株 | +1.88% | 8,900株 | -56.41% |
2018/03/02 | 日証協 | 282,000株 | -4.15% | 58,500株 | +346.36% | 371,459株 | +0.76% | 20,416株 | +112.67% |
2018/02/23 | 日証協 | 294,200株 | -16.09% | 13,106株 | -77.52% | 368,643株 | -5.1% | 9,600株 | -29.93% |
2018/02/16 | 日証協 | 350,600株 | +8.75% | 58,300株 | -48.32% | 388,443株 | +7.14% | 13,700株 | -84.38% |
2018/02/09 | 日証協 | 322,400株 | +13.4% | 112,806株 | -20.73% | 362,543株 | +3.1% | 87,700株 | +57.71% |
2018/02/02 | 日証協 | 284,300株 | +33.85% | 142,306株 | +421.15% | 351,643株 | +12.18% | 55,610株 | +67% |
2018/01/26 | 日証協 | 212,400株 | -26.71% | 27,306株 | -52.93% | 313,473株 | -11.84% | 33,300株 | +41.7% |
2018/01/19 | 日証協 | 289,800株 | +6% | 58,012株 | -13.16% | 355,573株 | +0.24% | 23,500株 | +164.04% |
2018/01/12 | 日証協 | 273,400株 | -4.2% | 66,806株 | +339.34% | 354,711株 | -3.3% | 8,900株 | +28.99% |
2018/01/05 | 日証協 | 285,400株 | +4.85% | 15,206株 | +31.05% | 366,811株 | +4.2% | 6,900株 | -75.96% |
2017/12/29 | 日証協 | 272,200株 | -2.51% | 11,603株 | +86.96% | 352,011株 | -3.27% | 28,700株 | +282.67% |
2017/12/22 | 日証協 | 279,200株 | +0.65% | 6,206株 | -63.93% | 363,911株 | +0.52% | 7,500株 | +41.51% |
2017/12/15 | 日証協 | 277,400株 | -0.54% | 17,206株 | -34.35% | 362,011株 | +0.5% | 5,300株 | -56.2% |
2017/12/08 | 日証協 | 278,900株 | +3.41% | 26,209株 | -2.23% | 360,211株 | +3.15% | 12,100株 | -26.22% |
2017/12/01 | 日証協 | 269,700株 | -6.58% | 26,806株 | -6.27% | 349,211株 | -2.27% | 16,400株 | +36.67% |
※株式分割は考慮していませんのでご注意ください。
Page Top